Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genes, Soy Isoflavones, and Virus - Preventing Airway Remodeling, Asthma, and Wheezing Study
NCT07828405Phase 2Not yet recruiting
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Oct 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 2, open-label trial of Hizofito in asthma (2 arms), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Primary endpoint: Eos3 transcriptional module expression. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
Hizofito
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07828405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07828405.